Etienne Giroux-Leprieur

12PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 11, 2026
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.

|Oct 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Gary Birsen, Valérie Gounant, Nicolas Girard

|Jan 26, 2024
Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations.

Marie Bellouard, Jean Donadieu, Pauline Thiebot

|Nov 14, 2023
Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer.

Lahcene Belaidi, Pascal Wang, Kevin Quintin

|Sep 28, 2023
Evaluation of Real-Life Chemoimmunotherapy Combination in Patients with Metastatic Small Cell Lung Carcinoma (SCLC): A Multicentric Case-Control Study.

Rémy Ezzedine, Anthony Canellas, Charles Naltet

|May 26, 2022
Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report.

Pierre Magdelaine, Adrien Costantini, Lucie Fabre

Pageof 2

Frequent Collaborators

3 joint publications

Marie Wislez

3 joint publications

Karen Leroy

3 joint publications

Elizabeth Fabre

2 joint publications

Boris Duchemann